Import 2 List

European Institute for Innovation and Technology (EIT) MedTech by European Commission awards exalt of the 10 finalists as best European MedTech Start-up in 2025

Staber and his team are now recruiting patients into a second prospective study in patients with hematological cancer, EXALT-2, which is comparing the utility of genomic screening, single-cell functional precision medicine and physicians’ choice in guiding therapy selection. 

exalt was invited for the Start-up pitch at the Falling Walls Sciencepreneurs Night 

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

exalt is selected as Winner of the Women-led tech start-up bootcamp in 2025 

All eyes are therefore on Staber and his randomized trial, which researchers anticipate will go a long way towards convincing clinicians that genomics is not the be-all and end-all of personalized care. "Paradigm shifts ... . 

exalt was voted as best deep tech start-up​​

Comparing functional and genomic-based precision medicine in blood cancer patients

Hemasphere 24 April 2025

Lukas Kazianka, Alexander Pichler, ..., Tea Pemovska et Philipp Staber

exalt receives support by the Austrian Promotional Bank Deep Tech Pre-Seed.

Best Tech-Start up prize in 2022. exalt was supported by the LBI Innovator's road program (Ludwig Boltzmann